Latest News

FDA names drugmakers potentially acting to delay cheap generics

(Reuters) - The U.S. Food and Drug Administration on Thursday listed drugmakers, including Celgene Corp , Johnson & Johnson , Gilead Sciences and Novartis AG , who the regulator says are potentially blocking access to samples of their drugs to delay generic competition.
Read The Rest at Reuters: Top News


Please Insert Your Name Please Insert Your E-Mail Please Write Your Comment Error Happened